Literature DB >> 1429232

Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. II. Structures of laxaphycins A, B, D and E.

W P Frankmölle1, G Knübel, R E Moore, G M Patterson.   

Abstract

Laxaphycins A and B are the major components in an antifungal mixture of cyclic peptides from the terrestrial blue-green alga Anabaena laxa FK-1-2. NMR and MS spectral studies coupled with amino acid analysis indicate that the gross structures of laxaphycins A and B are cyclic (Aoc-Hse-E-Dhb-Hyp-Hse-Phe-Leu-Ile-Ile-Leu-Gly) where Aoc is a 3-aminooctanoic acid residue and cyclic (Ala-Hleu-Gln-N-MeIle-Hasn-Thr-Pro-Leu-Thr-Ade-Val- Hleu) where Ade is a 3-aminodecanoyl unit, respectively. Laxaphycin E, a minor cyclic undecapeptide, differs in gross structure from laxaphycin A in possessing a 3-aminodecanoic acid unit (Ade) in lieu of Aoc, whereas laxaphycin D, a minor cyclic dodecapeptide, differs from laxaphycin B in possessing a 3-aminooctanoyl unit (Aoc) instead of an Ade unit.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429232     DOI: 10.7164/antibiotics.45.1458

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  19 in total

1.  Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.

Authors:  Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; Wei-Lun Chen; Jilai Yang; John L Woodard; James R Fuchs; Sang Hyun Cho; Scott G Franzblau; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2015-05-01       Impact factor: 3.641

2.  Targeted natural products discovery from marine cyanobacteria using combined phylogenetic and mass spectrometric evaluation.

Authors:  Lilibeth A Salvador-Reyes; Niclas Engene; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2015-01-30       Impact factor: 4.050

3.  Antifungal activity improved by coproduction of cyclodextrins and anabaenolysins in Cyanobacteria.

Authors:  Tania K Shishido; Jouni Jokela; Clara-Theresia Kolehmainen; David P Fewer; Matti Wahlsten; Hao Wang; Leo Rouhiainen; Ermanno Rizzi; Gianluca De Bellis; Perttu Permi; Kaarina Sivonen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

Review 4.  Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.

Authors:  George E Chlipala; Shunyan Mo; Jimmy Orjala
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

5.  Minutissamides A-D, antiproliferative cyclic decapeptides from the cultured cyanobacterium Anabaena minutissima.

Authors:  Hahk-Soo Kang; Aleksej Krunic; Qi Shen; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2011-06-23       Impact factor: 4.050

6.  Discovery of new A- and B-type laxaphycins with synergistic anticancer activity.

Authors:  Weijing Cai; Susan Matthew; Qi-Yin Chen; Valerie J Paul; Hendrik Luesch
Journal:  Bioorg Med Chem       Date:  2018-03-14       Impact factor: 3.641

Review 7.  Cyclic peptides and depsipeptides from cyanobacteria: a review.

Authors:  R E Moore
Journal:  J Ind Microbiol       Date:  1996-02

8.  Genetic variation of adenylation domains of the anabaenopeptin synthesis operon and evolution of substrate promiscuity.

Authors:  Guntram Christiansen; Benjamin Philmus; Thomas Hemscheidt; Rainer Kurmayer
Journal:  J Bacteriol       Date:  2011-05-27       Impact factor: 3.490

Review 9.  α,β-Dehydroamino acids in naturally occurring peptides.

Authors:  Dawid Siodłak
Journal:  Amino Acids       Date:  2014-10-17       Impact factor: 3.520

10.  Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater Cyanobacterium Trichormus sp. UIC 10339.

Authors:  Shangwen Luo; Aleksej Krunic; Hahk-Soo Kang; Wei-Lun Chen; John L Woodard; James R Fuchs; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2014-08-04       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.